Clinical Trials Logo
  1. Home
  2. Sepsis
  3. NCT05112406
  4. Details
NCT05112406 Clinical Trial

Early Diagnostic Biomarkers of Sepsis

Sepsis Clinical Trial

Official title:
A Comparison Between CRP, Ferritin and Serum Zinc as Early Diagnostic Biomarkers of Sepsis in Critically Ill Patients

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT05112406
Other study ID # Biomarkers of sepsis
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date December 2021
Est. completion date March 2023

Study information
Verified date November 2021
Source Assiut University
Contact Michael Kamile, MBBD
Phone +201554195616
Email michael.kamile@yahoo.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A Comparison between CRP, ferritin, and serum zinc as early diagnostic biomarkers of sepsis in critically ill patients

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 70
Est. completion date March 2023
Est. primary completion date December 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 95 Years
Eligibility Inclusion Criteria: - All patients with chest infection and UTI. Exclusion Criteria: - children

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Assiut University

Outcome
Type Measure Description Time frame Safety issue
Primary Study of some biomarkers as indicators of sepsis. Measurement of CRP as early diagnostic biomarker of sepsis about 2 years
Primary Study of some biomarkers as indicators of sepsis. Measurement of ferritin as early diagnostic biomarker of sepsis about 2 years
Primary Study of some biomarkers as indicators of sepsis. Measurement of serum Zinc as early diagnostic biomarker of sepsis about 2 years
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05095324 - The Biomarker Prediction Model of Septic Risk in Infected Patients
Completed NCT02714595 - Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens Phase 3
Completed NCT03644030 - Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
Completed NCT02867267 - The Efficacy and Safety of Ta1 for Sepsis Phase 3
Completed NCT04804306 - Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
Recruiting NCT05578196 - Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections. N/A
Terminated NCT04117568 - The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
Completed NCT03550794 - Thiamine as a Renal Protective Agent in Septic Shock Phase 2
Completed NCT04332861 - Evaluation of Infection in Obstructing Urolithiasis
Completed NCT04227652 - Control of Fever in Septic Patients N/A
Enrolling by invitation NCT05052203 - Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Recruiting NCT04005001 - Machine Learning Sepsis Alert Notification Using Clinical Data Phase 2
Completed NCT03258684 - Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock N/A
Recruiting NCT05217836 - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Completed NCT05018546 - Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery N/A
Completed NCT03295825 - Heparin Binding Protein in Early Sepsis Diagnosis N/A
Not yet recruiting NCT06045130 - PUFAs in Preterm Infants
Not yet recruiting NCT05361135 - 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia N/A
Not yet recruiting NCT05443854 - Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01) Phase 3